CDKN2A and cancer: This study, hence, compares the analytical performance of Leica Biosystems (LBS) developed monoclonal p16 antibody (clone 6H12) with the CINtec p16 (clone E6H4) assay in reference to the other commonly used assays, namely DNA ISH and PCR in OPSCC [26] cancer samples.